These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3930277)

  • 41. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
    Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
    Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accessory function and interleukin 1 production by human leukemic cell lines.
    Wakasugi H; Harel A; Dokhelar MC; Fradelizi D; Tursz T
    J Immunol; 1984 Jun; 132(6):2939-47. PubMed ID: 6373923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IFN-gamma-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate.
    Lian RH; Kotwal GJ; Wellhausen SR; Hunt LA; Justus DE
    J Immunol; 1996 Jul; 157(2):864-73. PubMed ID: 8752940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and -independent mechanisms.
    Watson CA; Petzelbauer P; Zhou J; Pardi R; Bender JR
    J Immunol; 1995 Apr; 154(7):3222-33. PubMed ID: 7897208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation and specificity of MNDA expression in monocytes, macrophages, and leukemia/B lymphoma cell lines.
    Briggs RC; Kao WY; Dworkin LL; Briggs JA; Dessypris EN; Clark J
    J Cell Biochem; 1994 Dec; 56(4):559-67. PubMed ID: 7890814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutting edge: phorbol ester induction of IFN-gamma receptors leads to enhanced DR alpha gene expression.
    Sakamoto S; Nie J; Taniguchi T
    J Immunol; 1999 Apr; 162(8):4381-4. PubMed ID: 10201972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular events induced in the HL 60 cell line following treatment with gamma-interferon.
    Dubreuil P; Courcoul M; Mannoni P
    Cancer Detect Prev; 1988; 12(1-6):15-21. PubMed ID: 3141051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
    Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS
    J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Expression of class I and class II markers on populations of leukemic cells].
    Tongio MM; Falkenrodt A; Urlacher A; Mitsuishi Y; Bergerat JP; Boilletot A; Lutz P; Griveau AM; Troussard X; Mayer S
    Pathol Biol (Paris); 1986 Jun; 34(6):753-7. PubMed ID: 3531991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The induction of class I HLA by interferon-alpha is independent of the cell cycle, but the expression is enhanced by a G1/S block.
    Erusalimsky JD; Gilmore D; Milstein C
    Eur J Immunol; 1987 May; 17(5):623-8. PubMed ID: 3108014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens.
    Kahn-Perles B; Wietzerbin J; Caillol DH; Lemonnier F
    J Immunol; 1985 Mar; 134(3):1759-65. PubMed ID: 2578520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical and immunological phenotype alterations in human monoblastoid cell line U-937 induced by physiological (interferon-alpha, retinoic acid) and nonphysiological (phorbol ester) inducers.
    Chorváth B; Sedlák J; Duraj J; Klobusická M; Plesková I; Augustinová M; Suliková M
    Neoplasma; 1990; 37(3):317-31. PubMed ID: 2196473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of HLA antigen expression on corneal epithelial and stromal cells.
    Dreizen NG; Whitsett CF; Stulting RD
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):933-9. PubMed ID: 3131265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modulation of the expression of HLA class II antigens by gamma interferon and phorbol ester TPA on myeloid leukaemic cell lines.
    Alonso MC; Navarrete C; Solana R; Ramirez R; Peña J; Festenstein H
    J Immunogenet; 1986; 13(2-3):255-61. PubMed ID: 3102618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of cell differentiation in Burkitt lymphoma lines. BLA: a glycolipid marker of B-cell differentiation.
    Balana A; Wiels J; Tetaud C; Mishal Z; Tursz T
    Int J Cancer; 1985 Oct; 36(4):453-60. PubMed ID: 3930411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of recombinant interferon-alpha and -gamma on B-CLL cells in serum-free medium: expression of activation, differentiation, and CALLA antigens.
    Tötterman TH; Danersund A; Carlsson M; Nilsson K
    Leukemia; 1987 Sep; 1(9):667-72. PubMed ID: 3118115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.